Generic selectors
Exact matches only
Search in title
Search in content
Post Type Selectors
Filter by Categories
Abstracts
Book Review
Case Report
Case Series
CMAS‡ - Pancreas - EUS-FNA Cytopathology (PSC guidelines) S1:1 of 5
CMAS‡ - Pancreas - EUS-FNA Cytopathology (PSC guidelines) S1:3 of 5
CMAS‡ - Pancreas - EUS-FNA Cytopathology (PSC guidelines) S1:4 of 5
CMAS‡ - Pancreas -Sampling Techniques for Cytopathology (PSC guidelines) S1:2 of 5
CMAS‡ - Pancreas- EUS-FNA Cytopathology (PSC guidelines) S1:5 of 5
Commentary
CytoJournal Monograph Related Review Series
CytoJournal Monograph Related Review Series (CMAS), Editorial
CytoJournal Monograph Related Review Series: Editorial
Cytojournal Quiz Case
Editorial
Erratum
Letter to Editor
Letter to the Editor
Letters to Editor
Methodology
Methodology Article
Methodology Articles
Original Article
Pap Smear Collection and Preparation: Key Points
Quiz Case
Research
Research Article
Review
Review Article
Systematic Review and Meta Analysis
View Point
View/Download PDF

Translate this page into:

Research Article
2023
:20;
19
doi:
10.25259/Cytojournal_34_2023

Diagnostic clues for hyalinizing trabecular tumor on fine needle aspiration cytology

Department of Pathology, Hospital Clínico San Carlos, Madrid, Spain
Department of Pathology, Hospital General Universitario Nuestra Señora del Prado, Talavera de la Reina, Spain
Corresponding author: Ana María Colino Gallardo, Department of Pathology, Hospital Clínico San Carlos, Madrid, Spain. amcolinog@gmail.com
Licence
This is an open-access article distributed under the terms of the Creative Commons Attribution-Non Commercial-Share Alike 4.0 License, which allows others to remix, transform, and build upon the work non-commercially, as long as the author is credited and the new creations are licensed under the identical terms.

How to cite this article: Nielsen L, Colino Gallardo AM, Pérez Alonso P, Ortega Medina L, Latorre García E, Díaz del Arco C, et al. Diagnostic clues for hyalinizing trabecular tumor on fine needle aspiration cytology. CytoJournal 2023;20:19.

Abstract

Objectives:

The hyalinizing trabecular tumor (HTT) is a rare benign neoplasm of the thyroid gland. This neoplasm has overlapping cytological features with Papillary Thyroid Carcinoma, Medullary Carcinoma and Follicular Neoplasm with Nuclear Features of Papillary Carcinoma. This can lead to misdiagnosis of malignancy in fine needle aspiration (FNA) cytology specimens with unnecessary total thyroidectomy. The aim of this study is to determine if there are some cytological features that could help us to suspect HTT on FNA specimens and avoid radical surgery.

Material and Methods:

With this purpose we have collected 6 cases diagnosed of HTT in Hospital Clínico San Carlos of Madrid (Spain) in the last 10 years and reviewed the cytological specimens.

Result:

We conclude that the presence of hyaline material in FNA specimens of HTT is a constant feature being a diagnostic clue. We must be cautious not to confuse it with dense colloid or amyloid material, the latter seen in Medullary Carcinoma. Papillary architecture and fibrovascular cores are not present in a HTT. Special stains as ki-67, calcitonin and Congo Red staining could help us in achieving the correct diagnosis.

Conclusion:

We feel the cytopathologists must be aware of the distinguishing features of this lesion, mainly the typical hyaline material to achieve a proper diagnosis and be able to reduce unnecessary aggressive management of these patients.

Keywords

Hyalinizing trabecular tumor
Hyaline material
Fine needle aspiration
Colloid
Nuclear pseudoinclusions

INTRODUCTION

Hyalinizing trabecular tumor (HTT) is a distinct rare benign neoplasm of the thyroid gland, first described in 1987 by Carney et al.[1]

This neoplasm arises from the follicular cells of the thyroid. It shows some architectural features that mimic malignancy on the fine needle aspiration (FNA) cytology specimens, including papillary thyroid carcinoma (PTC), medullary thyroid carcinoma (MTC), and non-invasive follicular thyroid neoplasm with papillary-like nuclear features. Therefore, it is estimated that FNA only reaches the right diagnosis in 8% of the cases.[2] This 92% false positive results rate can lead to an unnecessary partial or total thyroidectomy with the subsequent risks to the patients’ health and undue costs.[3-13]

The aim of this report is to review the cases of HTT diagnosed in our hospital in the past 10 years, emphasizing the cytologic features that can lead to a correct diagnosis and avoid an unnecessary total thyroidectomy.

MATERIAL AND METHODS

This is a retrospective case series from Hospital Clínico San Carlos in Madrid (Spain). Hospital Clínico is a large tertiary hospital with a population over 360,000 people and has a busy thyroid gland pathology outpatient clinic with dedicated head-and-neck radiologists and cytologists. All FNA cytologies are performed under ultrasonographic control with rapid on-site evaluation of the samples to increase diagnostic reliability.

We have performed a retrospective search of all thyroid gland resection specimens diagnosed as HTT and recorded in the electronic records (PAT-WIN) of the Pathology Department in the past 10 years.

The keywords used in the search were “hyalinizing” and “trabecular,” performing both searches separately. All cases found (n = 6) had a preoperative FNA, so we could include all the cases in the study.

The adequacy criteria for cytology samples were based on The Bethesda System for Reporting Thyroid Cytology as were the diagnosis categories employed for diagnostic classification of the cytology specimens.

In all the cases we had air-dried and alcohol fixed cytological specimens. A Papanicolaou stain had been performed at the time of diagnosis in the alcohol fixed specimens and a Diff-Quick stain in the air-dried ones. All patients had consented to their procedure following the institutional guidelines.

For the aim of this study, we only reviewed the original slides and did not perform either immunocytochemistry or molecular techniques in any of the cytologic samples.

The study has been reviewed and approved by the hospital institutional review board.

RESULTS

Our results are summarized in [Table 1]. In a 10-year period, we have diagnosed six cases of histology-proven HTT in our Hospital. We have a predominance of female gender with five females and one male. All patients were over 50 years of age, with a mean age of 61.3 years (range 52–68 years). Half of our lesions involved the isthmus of the thyroid. Two cases (33.3%) involved the left lobe and only one case the right lobe. The tumor size ranged from 0.7 cm to 4 cm. Most of the lesions were not larger than 2 cm (66.6%). Analyzing the ultrasonographic features, all the lesions were solid and hypoechogenic. Two of them showed microcalcifications. Only one case had a heterogeneous ultrasonographic pattern. In one case, the radiologists described a high intratumoral vascularity. Five of the six cases were diagnosed as suspicious of Follicular/Hürthle Cell Neoplasm (category IV), suspicious of PTC (category V), or positive for malignancy consistent with PTC (category VI). Only one of the cases was diagnosed as benign. In this case, the cytopathologist added a comment indicating that the cytological specimen was rich in Hürthle cells. None of them fell into the category of atypia of undetermined significance (Bethesda III). All of our patients underwent thyroidectomy and only one of them was partial. Two of these patients developed a postoperative hypothyroidism refractory to treatment with thyroid hormones. All the patients have other histologically-proven thyroid pathologies associated with the HTT. Three of them have multinodular goiter; two patients had lymphocytic thyroiditis (LT), and one patient has both pathologies. Before the diagnosis of HTT, three patients had undergone previous FNA and all of these cases had been diagnosed as category III of atypia of undetermined significance.

Table 1: Clinicopathological features of HTT in our series.
Features Number (n)
Sex
  Women 5
  Men 1
Mean age 61.3 (range: 52–68)
Laterality of lesions
  Left lobe 2
  Right lobe 1
  Isthmus 3
Tumor size
  ≤1 cm 1
  >1–≤2 cm 3
  >2 cm 2
Ultrasonographic features
  Hypoechogenic solid nodule 6
  Microcalcifications 2
  Heterogeneous 1
Bethesda cytological diagnostic categories
  II 1
  III 0
  IV 2
  V 1
  VI 2
Thyroidectomy
  Total 5
  Partial 1
  None 0
Associated thyroid pathologies
  MNG 3
  LT 2
MNG+LT 1
Previous FNA
  Yes 3
  No 3

HTT: Hyalinizing trabecular tumor, MNG: Multinodular Goiter, LT: Lymphocytic thyroiditis, FNA: Fine needle aspiration

Cytological findings

[Table 2] summarizes the cytological features of our cases. All the samples showed a bloody background with little or no colloid and the smears were hyper to moderately cellular. Only one case shows little dense colloid, resembling the chewing-gum aspect of PTC associated colloid. A thorough retrospective review of the slides revealed the presence of an extracellular hyaline material in all the cases [Figure 1]. In two of them, it was abundant and in the other four cases, it was more subtle. This material is diffusely distributed through the slides and it is frequently seen around the cell groups in a small quantity. This material was overlooked at the time of diagnosis, probably misinterpreted as dense colloid [Figures 1 and 2]. Two of the cases show psammomatous calcifications [Figure 2]. None of the cases have a papillary architecture, fibrovascular cores, or abundant discohesive cells. The cells are mainly arranged in large monolayered sheets or large to small cohesive groups. The cells present an ample polygonal/fusiform cytoplasm with no clear-cut cell borders. The nucleus is central or eccentrically placed with a low nucleus to cytoplasmic ratio. None of the cases present a nuclear clearing. Three of the cases present pseudoinclusions and nuclear grooves [Figures 3 and 4]. We identified nucleoli in all cases. In two of the cases, this finding was prominent.

Table 2: Cytological features of the six cases of HTT in our series.
Features Number (n)
Background
  Bloody 6
  Others 0
Cellularity
  High/moderate cellularity 6
  Low cellularity 0
Colloid
  Abundant 0
  Moderate 0
  Scant 1
Hyaline material
  Abundant/moderate 2
  Scant 4
Calcifications
  Present 2
  None 4
Architecture
  Papillary 0
  Fibrovascular cores 0
  Discohesive cells 0
  Other (large sheets, macro,
and microfollicles, trabecular sheets)
6
Cytoplasmic features
  Elongated/polygonal cells 6
  Other 0
Nuclear to cytoplasmic ratio
  High 0
  Low 6
Nuclear features
  Pseudoinclusions/grooves 3
  Chromatin clearing 0
Nuclei
  Macronucleoli 2
  Micronucleoli 4
  Absent 0

HTT: Hyalinizing trabecular tumor

Figure 1:
Hyaline material (a) with intermingled discohesive cells, one of them showing an intranuclear pseudoinclusion, in a bloody background. We must differentiate this material from the dense colloid (b) with a more homogeneous aspect, without intermingled cells and more blunt and sharp edges.
Figure 2:
(a and b) Hyaline material between small groups of polygonal/fusocellular shaped cells.
Figure 3:
Psammomatous calcifications.
Figure 4:
(a and b) Discohesive sheets of elongated cells with nuclear grooves and nuclear pseudoinclusions and scant hyaline material in the bloody background. The elongated features of the cells can lead to a misdiagnosis of medullary thyroid carcinoma.

DISCUSSION

HTT is a rare benign lesion that occurs between the four and seventh decade of life with a marked female predilection.[2]

The elongated or polygonal morphology of the cells together with the nuclear grooves and pseudoinclusions may lead to a misdiagnosis of PTC or FNNFPTC. The background hyaline material can be confused with MTC.[2,14-18]

HTT shows a distinctive cell membrane and cytoplasmic positivity for Ki-67, but only when clone MIB-1 is used and the reaction is performed at room temperature. It has been described both in cytological and histology specimens. If these peculiarities are not taken into account, it could result in a low-grade nuclear positivity and will lead to a misdiagnosis.[19] HTTs are also positive for thyroglobulin and thyroid transcription factor 1, although their staining are focal and weak with hector battifora mesothelial-1 and galectin. They are usually negative for cytokeratins, chromogranin, and calcitonin.

Recently, a rearrangement of PAX8-GLIS3, and less frequently PAX8-GLS1, has been discovered. This is a particular molecular alteration seen only in HTT and not in PTC. It could be a useful tool to distinguish between both entities.[20] All HTT demonstrated a BRAF wild-type phenotype. A BRAF mutation would exclude this entity favoring a PTC.[21-24] The immunohistochemical characteristics and molecular alterations of HTT and PTC are summarized in [Table 3].

Table 3: Comparative table of immunochemical and molecular features between HTT and PTC.
Entities HTT PTC
Immunochemical features
  Thyroglobulin Positive Positive
  TTF1 Positive Positive
  PAX8 Positive Positive
  HBME1 Positive (focal and weak) Positive (diffuse)
  Galectin-3 Positive (focal and weak) Positive (diffuse)
  Ki67 (MIB-1 clone) Positive (membranous) Positive (nuclear)
  CK19 Negative Positive
Molecular alterations
  BRAF V600E mutation - Present
  PAX8-GLIS3 rearrangement Present (most frequent) -
  PAX8-GLS1 rearrangement Present (less frequent) -

HTT: Hyalinizing trabecular tumor, PTC: Papillary thyroid carcinoma, TTF1: Thyroid transcription factor 1, HBME1: Hector battifora mesothelial-1

In our series of cases, imaging studies (ultrasonography, US) are not always a helpful tool in distinguishing a HTT from a PTC, due to the overlapping radiological features, such as microcalcifications.

However, in a recent review published by Scaglietti et al.,[2] they suggest that we have to keep in mind the diagnosis of HTT when the US suggest benignancy but the cytology specimen is suggestive for PTC.

A hypercellular or moderate cytology sample with scant or no colloid, the absence of papillary or fibrovascular structures with or without nuclear pseudoinclusions that does not fit in an exact Bethesda Category requires a careful search for the presence of hyaline material.

This hyaline material may be arranged in central cores surrounded by neoplastic cells or in the background of the sheets, like Scaglietti et al. reported.

We have to be careful not to misinterpret the hyaline material as colloid or amyloid. The latter is an acellular amorphous irregular fragment with scalloped or pointed edges, that stains eosinophilic with Papanicolaou stain and deep blue with Diff-Quick stain. To identify it on cytological specimens, we suggest the possibility to perform Congo Red Staining.[25] Distinction between hyaline material and colloid is exclusively morphological. The main problem is to distinguish dense colloid from the hyaline material. Colloid has net blunt edges as droplets and often shows glass-cracking appearance without fibrillary borders in contrast with the hyaline material of HTT. Colloid stains dark-blue with Diff-Quick Stain and orange-pink with Papanicolaou stain.

It could be helpful to perform immunochemistry with Ki-67 and molecular testing of mutations in BRAF. Even if we do not perform immunochemistry and molecular testing and we find some structures that suggest hyaline material, we could leave a note reporting that the cytology specimen has features of categories IV, V, or VI of Bethesda System, but we cannot exclude with certainty that the lesion is not a HTT. This leaves the surgeon a chance to evaluate the possibility of performing a partial thyroidectomy instead of a total thyroidectomy.

The presence of other concomitant thyroid pathologies may contribute to make the correct diagnosis more difficult and the coexistence with LT may push the cytopathologist to give a diagnosis of suspicious of PTC. It is recommended to keep in mind the high frequency of concomitant pathology in HTT.

This article has some limitations. First its retrospective nature and being based on histopathological diagnosis of this entity. We cannot be sure that some cases of this entity received a different diagnosis. In our hospital, the cytology reports did not use the Bethesda System until 2013. We have reclassified the prior cases based on the description made in the report. On the other hand, we have not full access to the radiological images, have not reviewed the cases and have only relied on the radiological report, so it is possible that we have missed some important radiological information.

CONCLUSION

HTT is a rare entity, frequently misdiagnosed in cytological samples. After reviewing our cases, we feel that the cytopathologists must be aware of the distinguishing features of this lesion, mainly the typical hyaline material and learn to differentiate it from other kinds of background material. We feel if we know this entity and its typical features proper diagnosis is possible with cytology and can reduce unnecessary aggressive management of these patients.

COMPETING INTEREST STATEMENT BY ALL AUTHORS

The authors declare no conflicts of interest regarding the publication of this paper.

AUTHORSHIP STATEMENT BY ALL AUTHORS

All authors declare that they are part of the current work through its ideation, development and revision.

ETHICS STATEMENT BY ALL AUTHORS

Study approval statement

This study protocol was reviewed and approved by Comité de Ética para la Asistencia Sanitaria (CEAS) of Hospital Clínico San Carlos, approval number [22-001].

Consent to publish statement

This study has informed consent for the use of data and images, which likewise are not linked to the patients in any way.

Data availability statement

The data used in this work are not available as they are in the private file of the Hospital Clínico San Carlos.

LIST OF ABBREVIATIONS (In alphabetic order)

FNA - Fine needle aspiration

FNNFPTC - Follicular neoplasm with nuclear features of papillary thyroid carcinoma

HBME1 - Hector battifora mesothelial-1

HTT - Hyalinizing trabecular tumor

LT - Lymphocytic thyroiditis

MNG - Multinodular goiter

MTC - Medyllary thyroid carcinoma

PTC - Papillary thyroid carcinoma

TTF1 - Thyroid transcription factor 1.

EDITORIAL/PEERREVIEW STATEMENT

To ensure the integrity and highest quality of CytoJournal publications, the review process of this manuscript was conducted under a double-blind model (the authors are blinded for reviewers and vice versa) through automatic online system.

FUNDING SOURCES

No specific funding was disclosed.

References

  1. , , . Hyalinizing trabecular adenoma of the thyroid gland. Am J Surg Pathol. 1987;11:583-91.
    [CrossRef] [PubMed] [Google Scholar]
  2. , , , . Hyalinizing trabecular tumour of the thyroid: Fine-needle aspiration cytological diagnosis and correlation with histology. J Clin Pathol. 2017;70:641-7.
    [CrossRef] [PubMed] [Google Scholar]
  3. , , , . Diagnostic dilemmas of hyalinizing trabecular tumours on fine needle aspiration cytology: A study of seven cases with BRAF mutation analysis. Cytopathology. 2011;22:407-13.
    [CrossRef] [PubMed] [Google Scholar]
  4. , , , . Hyalinizing trabecular tumor masquerading as papillary thyroid carcinoma on fine-needle aspiration. ORL J Otorhinolaryngol Relat Spec. 2014;75:309-13.
    [CrossRef] [PubMed] [Google Scholar]
  5. , , , , , , et al. Hyalinizing trabecular tumor of the hyroid: Diagnosis of a rare tumor using ultrasonography, cytology, and intraoperative frozen sections. Ultrasonography. 2016;35:131-9.
    [CrossRef] [PubMed] [Google Scholar]
  6. , , , . Hyalinizing trabecular tumor of the thyroid gland and its significant diagnostic issue. Thyroid Res. 2017;10:7.
    [CrossRef] [PubMed] [Google Scholar]
  7. , , , . Hyalinizing trabecular tumor of the thyroid gland, a diagnostic challenge in fine-needle aspiration cytology: Case report. J Pathol Transl Med. 2018;52:252-6.
    [CrossRef] [PubMed] [Google Scholar]
  8. , , , , , , et al. Cytological diagnosis difficulties in hyalinizing trabecular adenoma of the thyroid. J Endocrinol Invest. 2011;34:887-8.
    [CrossRef] [PubMed] [Google Scholar]
  9. , . Fine-needle aspiration biopsy cytology of hyalinizing trabecular adenomas of the thyroid. Diagn Cytopathol. 1999;20:90-4.
    [CrossRef] [Google Scholar]
  10. , , , . Lack of BRAF mutations in hyalinizing trabecular neoplasm. Cytojournal. 2006;25:17.
    [CrossRef] [PubMed] [Google Scholar]
  11. , , , , . Cytologic features of hyalinizing trabecular adenoma of the thyroid. Acta Cytol. 2003;47:399-404.
    [CrossRef] [PubMed] [Google Scholar]
  12. , . Clue helping to distinguish hyalinizing trabecular adenoma from carcinoma of the thyroid in fine-needle aspirates. Diagn Cytopathol. 1994;10:25-9.
    [CrossRef] [PubMed] [Google Scholar]
  13. , . Cytologic features of fine-needle aspirates of hyalinizing trabecular adenoma of the thyroid. Am J Clin Pathol. 1989;91:115-9.
    [CrossRef] [PubMed] [Google Scholar]
  14. , . The Bethesda System for Reporting Thyroid Cytopathology. (2nd ed). Berlin, Germany: Springer; .
    [CrossRef] [Google Scholar]
  15. , , , , , , et al. Nomenclature revision for encapsulated follicular variant of papillary thyroid carcinoma: A paradigm shift to reduce overtreatment of indolent tumors. JAMA Oncol. 2016;2:1023-9.
    [CrossRef] [PubMed] [Google Scholar]
  16. , , , , , , et al. Fine-needle aspiration diagnoses of noninvasive follicular variant of papillary thyroid carcinoma. Am J Clin Pathol. 2015;144:850-7.
    [CrossRef] [PubMed] [Google Scholar]
  17. , , , , , , et al. Young investigator challenge: The morphologic analysis of noninvasive follicular thyroid neoplasm with papillary-like nuclear features on liquid-based cytology: Some insights into their identification. Cancer Cytopathol. 2016;124:699-710.
    [CrossRef] [PubMed] [Google Scholar]
  18. , , , , , , et al. Impact of reclassifying noninvasive follicular variant of papillary thyroid carcinoma on the risk of malignancy in the Bethesda System for Reporting Thyroid Cytopathology. Cancer Cytopathol. 2016;24:181-7.
    [CrossRef] [PubMed] [Google Scholar]
  19. , , , , , , et al. Cell membrane reactivity of MIB-1 antibody to Ki67 in human tumors: Fact or artifact? Appl Immunohistochem Mol Morphol. 2007;15:220-3.
    [CrossRef] [PubMed] [Google Scholar]
  20. , , , , , , et al. GLIS rearrangement is a genomic hallmark of hyalinizing trabecular tumor of the thyroid gland. Thyroid. 2019;29:161-73.
    [CrossRef] [PubMed] [Google Scholar]
  21. , , , , , . Hyalinizing trabecular tumour of the thyroid-differential expression of distinct miRNAs compared with papillary thyroid carcinoma. Histopathology. 2010;56:632-40.
    [CrossRef] [PubMed] [Google Scholar]
  22. , , , , , , et al. Galectin-3 expression in hyalinizing trabecular tumors of the thyroid gland. Am J Surg Pathol. 2003;27:494-8.
    [CrossRef] [PubMed] [Google Scholar]
  23. , , , , , , et al. Stromal tiny black dots, like “sugarcoated”, of von Kossa stain is a diagnostic clue to hyalinizing trabecular tumor of the thyroid gland. Pathol Int. 2018;68:176-82.
    [CrossRef] [PubMed] [Google Scholar]
  24. , , , . HBME-1 expression in hyalinizing trabecular tumours of the thyroid gland. Histopathology. 2013;62:1092-7.
    [CrossRef] [PubMed] [Google Scholar]
  25. , . Amyloid in cytologic specimens. Differential diagnosis and diagnostic pitfalls. Acta Cytol. 1999;43:746-55.
    [CrossRef] [PubMed] [Google Scholar]
Show Sections